FeesSafety
Pluang+

Closed-end fund discounts hit widest level since April 2024, nearing -10% median discount.

19 Nov 2026, 19:24 WIB
Seeking Alpha
View Source
Bullish
Closed-end fund discounts hit widest level since April 2024, nearing -10% median discount.

Closed-end funds (CEFs) saw their median discount to net asset value (NAV) widen to -9.67% by November 13, 2026, the largest month-end discount since April 2024, compared to -6.32% a year earlier. Nearly half of all CEFs now trade at double-digit discounts, with 61% cheaper than their own one-year history. The biggest discount widening occurred in fixed income and real estate CEFs, while NAVs remained mostly flat, indicating losses stemmed from discount expansion rather than asset value declines. Historically, such discount cycles have preceded strong portfolio returns, as seen in 2019 and 2024, suggesting potential opportunities for investors.

Closed-end funds discounts widened significantly by mid-November 2026, reaching the largest month-end discount since April 2024. For readers following US stocks on Pluang, here is the market snapshot as of Nov 20, 2026 00:11 WIB: out of 150 priced stocks, 14 rose and 136 fell. Notable movers include UPST at USD 17.09 with a 1-day change of -5.21% and 100% buy order activity, SPCE at USD 1.14 down 5.00% with 95% buy orders, and ACN at USD 216.53 down 4.82% with 82% sell orders.

More News

Brain cancer diagnostics market to nearly double by 2034, driven by tech advances and rising tumor cases.

Brain cancer diagnostics market to nearly double by 2034, driven by tech advances and rising tumor cases.

The global brain cancer diagnostics market is projected to grow from USD 4.1 billion in 2025 to USD 9.85 billion by 2034, at a CAGR of about 10.2%. Growth is fueled by increasing brain tumor incidence, adoption of advanced imaging and molecular diagn...

Bullish
55 minutes ago
Google switches satellite launch partner from SpaceX to Blue Origin for AI project.

Google switches satellite launch partner from SpaceX to Blue Origin for AI project.

Google initially launched its first Project Suncatcher AI satellite with SpaceX but has now signed a launch agreement with Blue Origin for a dedicated mission in early 2029. This shift comes amid SpaceX's threat to halt future Falcon 9 commercial lau...

Market News
Bullish
57 minutes ago
Adobe and Synopsys compete as top tech growth picks with distinct strengths and risks for 2027 investors.

Adobe and Synopsys compete as top tech growth picks with distinct strengths and risks for 2027 investors.

Adobe leads in creative software with strong revenue growth and a new AI partnership with Disney, offering stable long-term prospects despite management changes. Synopsys excels in semiconductor design tools, boosted by its Ansys acquisition and expa...

Bullish
58 minutes ago
Sandisk's stock drops two-thirds despite net income quadrupling, making it a potential buy at 6 times earnings.

Sandisk's stock drops two-thirds despite net income quadrupling, making it a potential buy at 6 times earnings.

Sandisk's net income for the trailing 12 months has surged to around $19.4 billion, more than four times its level in June, while its stock price has fallen to about a third of its June peak. This drop means the stock now trades at roughly 6 times ea...

Market News
Bullish
59 minutes ago
Vertex and Regeneron rebound with strong drug pipelines and new product approvals boosting growth.

Vertex and Regeneron rebound with strong drug pipelines and new product approvals boosting growth.

Vertex Pharmaceuticals is poised for growth with potential FDA approval of povetacicept for kidney disease and a strong cystic fibrosis drug franchise, alongside a $10 billion acquisition expanding its pipeline. Regeneron is thriving with Dupixent's ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App